SBWire

With retail values rising to US$465 billion in 2012, global bakery still offers good growth potential. Added value innovation focusing on health and convenience is strongly driven by developed markets, as obesity and time pressures mount. However, emerging market consumers are also becoming more willing - and able - to spend more on added value formats, such as high fibre. Meanwhile, volatile input costs, coupled with clean label and other ingredient trends, continue to drive product development...

With the total toys and games market worth over Rp5 trillion, Indonesia is eligible to hold the title of being the next lucrative toys and games market. Traditional toys and games accounts for more than 80% of the total market, with the construction toys category being the highest contributor. On the other hand, entering the digital era, the video games category should not be underestimated. This is not only due to the increasing gaming population in Indonesia, but also supported by the rising...

GlobalData's report, Bisphenol A Industry Outlook in the US to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of the US Bisphenol A industry. The research presents major market trends affecting the Bisphenol A industry in the US. The report covers the US Bisphenol A plants and presents installed capacity by process and technology. In addition, it presents Bisphenol A demand and production forecasts, end use demand forecasts, price trends, trade balance data and company shares of the major Bisphenol A producers in the US. Overall, the report presents a comprehensive coverage of the US Bisphenol A industry including all the major parameters.

The accompanying tables present the latest economic data and five-year forecast scenario for the country's banking system. Also included is SWOT analysis of the commercial banking system as a whole.

Food consumption is expected to increase steadily over our five-year forecast period, reaching a projected HRK14.17bn by 2017, which represents a modest local currency compound annual growth rate of 2.4% on 2012 levels. The overall value will remain low by Western European standards. Croatia's subdued longer-term demographic outlook will play a part in such market dynamics. In 2012, we expect that food consumption will have increased slightly, by 0.5% in local currency terms. This outlook is based on the expected continuation of a challenging economic situation, including high unemployment and a VAT increase, which will continue to negatively impact consumer confidence and thus also favour cheaper private label products.

Political uncertainty will continue to affect the Egyptian economy in 2013 as the country continues upon its rocky transitional period towards democracy. This uncertainty will, in turn, continue to affect the freight transport sector as a worsening economic position will impact on the country's demand for cargo transportation, either as a result of muted private consumption or a lack of significant infrastructure projects as foreign direct investment dries up. As a result our forecasts for the Egyptian rail and air freight and the ports sector are largely sedate, though the transhipment hub of East Port Said - less reliant on domestic demand - is expected to outperform.

Elevated government spending, strong banking sector credit and consequently strong private consumption in Bahrain have prompted BMI to slightly revise up its new vehicle sales forecast for 2012. We now expect the market to shift a total of 52,900, against the estimated 50,400 vehicles sold in 2011- growing nearly 5% y-o-y, compared with the 3.5% y-o-y growth expected earlier.

Global Market Direct's pharmaceuticals report, "AiCuris GmbH & Co. KG - Product Pipeline Review - 2012" provides data on the AiCuris GmbH & Co. KG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

A detailed market research report on the UK beer industry. Researched and published by Canadean.

GlobalData's clinical trial report, "Ventricular Arrhythmia Global Clinical Trials Review, H2, 2012" provides data on the Ventricular Arrhythmia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Arrhythmia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ventricular Arrhythmia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "Republic of Korea Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others" provides key market data on the Republic of Korea Patient Monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories - Fetal Monitors, Micro-Electromechanical Systems, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Patient Monitoring Accessories . The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

GlobalData's new report, "Bovie Medical Corporation Market Share Analysis" provides in-depth information on Bovie Medical Corporation's market position in the different medical equipment markets it operates in. The report provides Bovie Medical Corporation market share information in one key market category - Electrosurgical Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

"Apache Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into "Apache Corporation". The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company's business structure, operations and products, and provides an analysis of its key revenue lines.

GlobalData's new report, "North America Patient Monitoring Market Outlook to 2018 - Fetal Monitors, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors and Others" provides key market data on the North America Patient Monitoring market - Canada and United States. The report provides value (USD million) data for all the market categories - Fetal Monitors, Micro-Electromechanical Systems, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Patient Monitoring Accessories and Remote Patient Monitoring. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Global Market Direct's pharmaceuticals report, "REGiMMUNE Corporation - Product Pipeline Review - 2012" provides data on the REGiMMUNE Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Market Direct's pharmaceuticals report, "Quest PharmaTech Inc. - Product Pipeline Review - 2012" provides data on the Quest PharmaTech Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Global Markets Direct's, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Ovarian Cancer. Metastatic Ovarian Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Kidney Cancer (Renal Cell Cancer). Kidney Cancer (Renal Cell Cancer) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Oligodendroglioma - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Oligodendroglioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Oligodendroglioma. Oligodendroglioma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Neuroendocrine Tumors - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Neuroendocrine Tumors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuroendocrine Tumors. Neuroendocrine Tumors - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura). Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's, 'Pulmonary Arterial Hypertension - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Arterial Hypertension, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Pulmonary Arterial Hypertension. Pulmonary Arterial Hypertension - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Global Markets Direct's new report, "Hungary Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2018", provides key market data on the Hungary Patient Monitoring market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - Fetal Monitors, Micro-Electromechanical Systems, Multiparameter Patient Monitoring, Neonatal Monitors, Non-Invasive Blood Pressure Monitors, Patient Monitoring Accessories and Remote Patient Monitoring. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.

Bring your own device (BYOD) has become one of the most popular topics in information technology resulting from employees bringing their personal devices into the enterprise and then wanting to use them to access company information such as email and various enterprise files.

The overall tobacco market in China registered steady growth in volume sales in 2011, even though this was at a slightly slower pace than in previous years. Steadily increasing demand was the main driving force for the sustainable growth. Despite price increases caused by tax adjustments, as well as public smoking bans implemented by the government, there was little impact on the growth of tobacco in China.